Soroka Stephen D, Granade Timothy C, Candal Debra, Parekh Bharat S
Division of HIV/AIDS Prevention, National Center for HIV/AIDS, STD, and TB Prevention, Atlanta, GA 30333, USA.
Clin Diagn Lab Immunol. 2005 Aug;12(8):918-21. doi: 10.1128/CDLI.12.8.918-921.2005.
Assay protocols of three rapid human immunodeficiency virus (HIV) assays, OraQuick-1/2, SeroStrip-1/2, and Determine-1/2, were modified to detect recent HIV seroconversion using a higher dilution of serum specimens. Optimal predilution of specimens resulted in negative test results during early periods of seroconversion (about 6 months), when antibody levels were low. A total of 269 seropositive specimens from routine HIV type 1 testing and from commercial sources (low-titer and seroconversion panels) were tested, and results were recorded as negative (score=0) or positive using intensity scores from 0.5 (weak positive) to 4 (strongly positive). The same specimens were previously tested by a less sensitive (LS) enzyme immunoassay (EIA), Abbott 3A 11-LS, and were classified as recent or long-term infections based on the standardized optical density (SOD) cutoff of 0.75. Overall concordance of >94% was observed between 3A 11-LS and modified rapid tests (RT-LSs) for detecting and distinguishing recent HIV seroconversion from long-term HIV infection (kappa statistics=0.894 to 0.901). Moreover, intensity scores on RT-LSs correlated well with median 3A 11-LS SOD values (R(2)>0.98). Our results indicate that rapid HIV tests can be modified to detect recent seroconversion with results comparable to those from less sensitive EIA.
三种快速人类免疫缺陷病毒(HIV)检测方法,即奥拉克快检-1/2、血清试纸-1/2和确定-1/2的检测方案进行了修改,以使用更高稀释度的血清标本检测近期HIV血清转化。标本的最佳预稀释导致在血清转化早期(约6个月)抗体水平较低时检测结果为阴性。对来自常规1型HIV检测和商业来源(低滴度和血清转化样本组)的269份血清阳性标本进行了检测,并使用从0.5(弱阳性)到4(强阳性)的强度评分将结果记录为阴性(评分=0)或阳性。相同的标本先前通过灵敏度较低的(LS)酶免疫测定(EIA),即雅培3A 11-LS进行检测,并根据标准化光密度(SOD)截断值0.75分为近期感染或长期感染。在检测和区分近期HIV血清转化与长期HIV感染方面,观察到3A 11-LS与改良快速检测(RT-LS)之间的总体一致性>94%(kappa统计量=0.894至0.901)。此外,RT-LS上的强度评分与3A 11-LS SOD中位数很好地相关(R²>0.98)。我们的结果表明,快速HIV检测可以进行修改以检测近期血清转化,其结果与灵敏度较低的EIA相当。